Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis. 2000

L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
The University of Texas M.D. Anderson Cancer Center, Science Park-Department of Veterinary Sciences, Bastrop, TX 78602, USA.

The development and initial characterization of five new inbred strains of SENCAR mice are described in this paper. Ten randomly selected pairs of outbred SENCAR mice were mated and offspring from each separately maintained parental line were sib mated at each successive generation to result in inbred strains. Due to poor reproductive performance only five of the original 10 lines were bred to homogeneity. Initial characterization of the five remaining lines (referred to as SL2/sprd, SL5/sprd, SL7/sprd, SL8/sprd and SLl0/sprd) at F12 for their responsiveness to a two-stage carcinogenesis protocol (10 nmol 7,12-dimethylbenz[a]anthracene and 0.25 microg 12-O-tetradecanoylphorbol-13 acetate) revealed three groups of responders in terms of the number of papillomas per mouse: SL2/sprd and SL8/sprd > SL7/sprd and SL10/sprd >> SL5/sprd. The papilloma responses in SL2/sprd and SL8/sprd were very similar to SENCAR B/Pt compared at the same doses. Papillomas induced on SL2/sprd had the highest propensity to progress to squamous cell carcinomas, similar to that observed in outbred SENCAR and SENCAR B/Pt mice. More detailed comparison of the responsiveness of SL2/sprd and SL5/sprd at Fl5 showed that these two inbred strains differed in their sensitivity to TPA-induced epidermal hyperplasia and that the dose of TPA required to produce a tumor response in SL5/sprd in comparison with that in SL2/sprd was 4-20 times higher. Overall, the availability of the different inbred SENCAR strains will greatly aid mechanistic studies of multistage skin carcinogenesis as well as studies to understand the underlying genetic basis of resistance to tumor promotion and progression in this model system.

UI MeSH Term Description Entries
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D015127 9,10-Dimethyl-1,2-benzanthracene Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen. 7,12-Dimethylbenzanthracene,7,12-Dimethylbenz(a)anthracene,7,12 Dimethylbenzanthracene
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018632 Mice, Inbred SENCAR Mice selectively bred for hypersusceptibility to two-stage chemical skin carcinogenesis. They are also hypersusceptible to UV radiation tumorigenesis with single high-dose, but not chronic low-dose, exposures. SENCAR (SENsitive to CARcinogenesis) mice are used in research as an animal model for tumor production. Mice, SENCAR,Mouse, Inbred SENCAR,Mouse, SENCAR,Inbred SENCAR Mice,Inbred SENCAR Mouse,SENCAR Mice,SENCAR Mice, Inbred,SENCAR Mouse,SENCAR Mouse, Inbred

Related Publications

L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
September 1997, Molecular carcinogenesis,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
July 1995, Proceedings of the Association of American Physicians,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
June 1995, Cancer metastasis reviews,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
January 1991, Progress in experimental tumor research,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
April 1989, Alcoholism, clinical and experimental research,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
December 1991, Cancer letters,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
September 1994, Molecular carcinogenesis,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
December 1966, Indian journal of medical sciences,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
September 2002, Molecular carcinogenesis,
L G Coghlan, and I Gimenez-Conti, and H E Kleiner, and S M Fischer, and J E Rundhaug, and C J Conti, and T J Slaga, and J DiGiovanni
September 1986, Environmental health perspectives,
Copied contents to your clipboard!